PRF1 and neoplasm: Upon directly recognizing cancer cells, TR-CD4 express an array of effector molecules, including IL-2, IFN-γ, TNF-α, perforin and granzyme, which play critical roles in inhibiting cancer cell growth and orchestrating anti-tumor immune responses.